Gouty arthritis, gouty tophi: the reality of a non-compliant patient (case report)
DOI:
https://doi.org/10.32385/rpmgf.v42i1.14214Keywords:
Gout, Gouty arthritis, Gouty tophi, Medication adherence, Health educationAbstract
Introduction: Gout is an inflammatory disease caused by the buildup of uric acid crystals in the joints and surrounding tissues. If untreated, gout can progress to a chronic form, leading to the formation of tophi and potentially severe joint damage, including ulceration.
Case description: This case report presents a patient who developed a severe case of ulcerated gouty arthritis due to non-adherence to treatment.
Comments: This patient’s non-adherence to both medical follow-up and medication therapy led to the worsening of their condition, with a negative personal impact, as well as an inadequate use of medical and pharmacological resources. Health education, effective communication between healthcare professionals and patients, and regular follow-up are essential to prevent complications and improve patients’ quality of life with gout.
Downloads
References
1. Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11-6.
2. Ragab G, Elshahaly M, Bardin T. Gout: an old disease in new perspective – A review. J Adv Res. 2017;8(5):495-511.
3. Batista JS, Wibelinger LM. Artrite gotosa no processo de envelhecimento humano [Gouty arthritis in the human aging process]. Kairós Gerontol. 2011;14(4):123-34. Portuguese
4. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011;23(2):192-202.
5. Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380-90.
6. Tao H, Mo Y, Liu W, Wang H. A review on gout: looking back and looking ahead. Int Immunopharmacol. 2023;117:109977.
7. Abhishek A, Roddy E, Doherty M. Gout: a guide for the general and acute physicians. Clin Med (Lond). 2017;17(1):54-9.
8. Falidas E, Rallis E, Bournia VK, Mathioulakis S, Pavlakis E, Villias C. Multiarticular chronic tophaceous gout with severe and multiple ulcerations: a case report. J Med Case Rep. 2011;5:397.
9. Perez-Ruiz F, Desideri G. Improving adherence to gout therapy: an expert review. Ther Clin Risk Manag. 2018;14:793-802.
10. Rees F, Hui M, Doherty M. Optimizing current treatment of gout. Nat Rev Rheumatol. 2014;10(5):271-83.
11. Vincent ZL, Gamble G, House M, Knight J, Horne A, Taylor WJ, et al. Predictors of mortality in people with recent-onset gout: a prospective observational study. J Rheumatol. 2017;44(3):368-73.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
